glycidamide has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alm, IM; Andersen, JM; Dirven, H; Duale, N; Holme, JA; Lauvås, AJ; Lislien, M; Macko, P; Myhre, O; Paulsen, RE; Pistollato, F; Skarpen, E; Sørensen, V | 1 |
| Lee, C; Lee, YJ; Sim, KH; Triningsih, D; Yang, JH | 1 |
2 other study(ies) available for glycidamide and Encephalopathy, Toxic
| Article | Year |
|---|---|
Developmental neurotoxicity of acrylamide and its metabolite glycidamide in a human mixed culture of neurons and astrocytes undergoing differentiation in concentrations relevant for human exposure.
Topics: Acrylamide; Astrocytes; Brain-Derived Neurotrophic Factor; Epoxy Compounds; Female; Humans; Induced Pluripotent Stem Cells; Infant, Newborn; Microtubule-Associated Proteins; Nestin; Neurons; Neurotoxicity Syndromes; Pregnancy; Tubulin | 2022 |
Acrylamide and its metabolite induce neurotoxicity via modulation of protein kinase C and AMP-activated protein kinase pathways.
Topics: Acrylamide; AMP-Activated Protein Kinases; Animals; Autophagy; Cytochrome P-450 CYP2E1; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Neurotoxicity Syndromes; PC12 Cells; Protein Kinase C; Rats; RNA, Small Interfering | 2021 |